On March 5, 2024 Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, reported that members from the Replimune management team will present and host investor meetings at the following three conferences (Press release, Replimune, MAR 5, 2024, View Source [SID1234640791]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Leerink Partners 2024 Global Biopharma Conference
Date: Tuesday, March 12, 2024
Fireside Chat Time: 2:20 pm EDT

Jefferies Biotech on the Bay Miami Summit
Date: Wednesday, March 13, 2024

Barclays 26th Annual Global Healthcare Conference
Date: Thursday, March 14, 2024
Fireside Chat Time: 10:45 am EDT

Live webcasts of the Leerink and Barclays fireside chats will be available in the Investors section of Replimune’s website at www.replimune.com. A replay will be available for 30 days following the conference.